ClinicalTrials.Veeva

Menu

Establishing First Trimester Markers for the Identification of High Risk Twin

S

Shamir Medical Center (Assaf-Harofeh)

Status

Unknown

Conditions

Pre-Eclampsia
Small for Gestational Age (Disorder)

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this study is to determine whether we can establish different markers suc as mean arterial pressure , flow in the uterine arteries, biochemical markers in maternal blood and more un the first trimester, in order to screen for twin pregnancies that are more likely to develop adverse pregnancy outcome: early delivery, pre eclampsia or small fetuses.

Enrollment

300 estimated patients

Sex

Female

Ages

18 to 50 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • pregnant women from 11 -14 weeks of gestation

Exclusion criteria

  • nuchal thickness above 3 mm,
  • Chronic hypertension,
  • thrombophilia,
  • Diabetes

Trial design

300 participants in 2 patient groups

singelton pregnancy
Description:
will be followed 11-14 weeks and 19-28 weeks of gestation and after birth
twin pregnancy
Description:
will be followed 11-14 weeks and 19-28 weeks of gestation and after birth

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems